Rivio
3 known investors
Rivio provides an AI-powered revenue cycle management service for hospitals, handling auditing, insurance claim submission, denial appeals, and hidden revenue recovery. It contractually guarantees full reimbursement from health insurance plans and serves the Brazilian healthcare market.
Also known as Rivio
Investors · 3
Also in the syndicate · 1
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Company profile
researched Aug 2026Rivio is a Brazilian B2B healthtech that applies artificial intelligence to hospital revenue cycle management. Its platform covers the full cycle from medical-bill auditing through billing submission and post-billing recovery: AI agents perform preventive, concurrent and retrospective audits of 100% of accounts, build a clinical timeline per patient from prescriptions, nursing notes and procedure records, and cross-reference those records against the account to catch unbilled items, prices above contract and incompatible codes before they generate denials (glosas). The system centralizes and automates submission of the XML billing files to each health plan operator according to that operator's contractual rules, and after submission its agents interpret returned denial files, classify inconsistencies and automatically assemble technical appeals, supervised by Rivio's in-house billing specialists. A "hidden revenue discovery" module identifies materials and procedures performed but omitted from the bill, and a dashboard gives hospitals real-time visibility over the cycle.
The architecture is described as a set of specialized, autonomous agents that pass work between each other — an Auditing Agent, a Contracts Agent that extracts rules and price tables from operator documents, a Price Review Agent, a Denial Analysis Agent and a Denial Appeal Agent. The platform integrates with the main hospital ERPs used in Brazil, including Tasy, MV, Pixeon, Wareline and SPDATA. Rivio states a longer-term ambition to become the administrative operating system for healthcare in Latin America, starting with the revenue cycle. The company was created in 2025 and the platform was built by more than 50 professionals.
Founding story
Rivio was created in 2025 by Silvio Frison (Co-Founder and CEO) and Ricardo Sales, both holders of graduate degrees from Stanford GSB, around the thesis that hospital revenue cycle inefficiency is a structural, under-addressed problem. Frison previously founded and led Serasa Consumidor at Serasa Experian — described as the world's largest credit and debt marketplace — and founded and sold Pense Imóveis and Busca Carros, also leading strategy at Active Network through its IPO. Sales is an ITA-trained engineer who co-founded Isaac, a Latin American education fintech backed by SoftBank, General Atlantic and Kaszek that was acquired by Arco, and was previously a vice president at General Atlantic. Gustavo Meirelles, a physician and health innovation leader (VP at Afya, formerly Fleury), is listed as an advisor [0][2][4].
Business model
Rivio sells an end-to-end managed service rather than software alone: it takes over the hospital's revenue cycle operation (auditing, billing submission, denial appeals and collection) using AI agents supervised by its own billing specialists. Its central commercial differentiator is a contractual performance guarantee — Rivio commits that 100% of health-plan encounters will be reimbursed and denials eliminated, and covers the difference itself if the hospital is not paid in full, shifting operational and financial risk from the provider to Rivio [0][3][4][6].
Traction
The company reported more than 30 hospitals in its portfolio as of October 2025 and technology in implementation at more than 50 hospital units nationwide as of February 2026. Rivio states that partner hospitals raised revenue by roughly 5% in the first month of operation, citing an Exame report of 15 January 2026. Its site displays aggregate impact counters for audited revenue, accounts analyzed, encounters audited and work hours saved [3][4].
Latest developments
Between December 2025 and February 2026 Rivio announced a total of USD 21 million raised across two rounds plus an extension: a round led by Monashees, another led by New York-based Valor Capital Group with participation from Endeavor (first reported by Valor Econômico on 17 December 2025 at R$ 100 million / US$ 20 million and a R$ 500 million valuation), and a US$ 1 million Series A extension from impact investor Positive Ventures, reported exclusively by Bloomberg Línea on 4 February 2026 [0][4][7].
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Rivio positions itself as the only company in the Brazilian hospital revenue-cycle segment offering a contractual reimbursement guarantee, contrasting its model with vendors that supply digital auditing systems or automated checking tools while leaving financial responsibility with the hospital. Its own blog cites the December 2025 round as one of the largest investments made in a Latin American healthcare company less than a year old [3][4][7].
The contractual performance guarantee (Rivio absorbs the shortfall if the hospital is not reimbursed 100% by health plans), auditing of 100% of accounts rather than samples, delivery as a full service including denial appeals rather than as licensed software, and a multi-agent AI architecture integrated with incumbent hospital ERPs [0][3][4].
Technology
A multi-agent AI platform in which each agent handles one stage of the revenue cycle and operates continuously without per-action human commands: auditing (reading clinical free text such as prescriptions and nursing evolutions and reconciling it with the billed account), contract ingestion (extracting operator rules and price tables), price review, denial analysis and automated denial appeal drafting. The platform is integrated with major Brazilian hospital ERPs (Tasy, MV, Pixeon, Wareline, SPDATA) and automates AI-validated XML submission to payers, with traceability of each decision [0][3].
Go-to-market
Healthcare providers in Brazil — hospitals and clinics — that serve health insurance plans, have a hospital ERP installed, and bill more than R$ 1 million per month to health plans. The company says its portfolio includes some of the largest hospital brands in the country [3][4].
Geography
Brazil, with hospital units across the country; the founders' stated ambition is to become the main administrative operating system for healthcare in Latin America [4][6].
History
Founded in 2025 (Valor Econômico described the startup as six months old in December 2025). The platform was built by a team of more than 50 professionals, and by October 2025 the company reported over 30 hospitals in its portfolio. A first funding round led by Monashees and a second led by Valor Capital Group with Endeavor were announced in December 2025, followed by a Series A extension from Positive Ventures announced in early February 2026, bringing announced capital to USD 21 million [0][3][4][7].
Risks & controversies
Rivio's contractual guarantee to cover any shortfall in health-plan reimbursement places the operational and financial risk of denials on Rivio itself rather than the hospital. The company also describes its technology as recent and still evolving while being deployed at more than 50 hospital units [3][4].
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 3
launches, deals, and filingsIn a company blog post, Rivio said that between December 2025 and February 2026 it announced the raising of USD 21 million in total, via a round led by Monashees, a round led by Valor Capital Group with participation from Endeavor, and a US$ 1 million extension from Positive Ventures.
$21M source ↗
Rivio announced the entry of impact investor Positive Ventures with a US$ 1 million investment characterized as an extension of its Series A; Positive Ventures founding partner Fabio Kestenbaum commented on the investment to Bloomberg Linea, which reported it exclusively on 4 February 2026.
$1M source ↗
Valor Econômico reported that Rivio, then six months old, raised R$ 100 million (US$ 20 million) from Valor Capital and Monashees plus Endeavor, at a reported valuation of R$ 500 million.
$20M source ↗
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 8
primary sources listed
- Riviorivio.com.br · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Rivio do?
- Brazilian healthtech using AI agents to run hospital revenue cycle management with a contractual guarantee of full payer reimbursement.
- Who are Rivio's investors?
- Rivio's investors include MONASHEES, Valor Capital Group.
